Procalcitonin (PCT) as a biomarker in hospital acquired septicemia in neonatal intensive care unit (NICUS) and pediatric intensive care unit (PICUS)in Aswan university hospital
Moubarak, I., Elanany, M., Osman, A., Gabari, M., Mohammed, I., Moubarak, I. (2024). Procalcitonin (PCT) as a biomarker in hospital acquired septicemia in neonatal intensive care unit (NICUS) and pediatric intensive care unit (PICUS)in Aswan university hospital. EKB Journal Management System, (), -. doi: 10.21608/aumj.2024.246809.1087
Islam Ahmed Moubarak; Mervat Elanany; Asmaa Osman; Magda Farghalli Gabari; Islam Mohammed; Islam Ahmed Moubarak. "Procalcitonin (PCT) as a biomarker in hospital acquired septicemia in neonatal intensive care unit (NICUS) and pediatric intensive care unit (PICUS)in Aswan university hospital". EKB Journal Management System, , , 2024, -. doi: 10.21608/aumj.2024.246809.1087
Moubarak, I., Elanany, M., Osman, A., Gabari, M., Mohammed, I., Moubarak, I. (2024). 'Procalcitonin (PCT) as a biomarker in hospital acquired septicemia in neonatal intensive care unit (NICUS) and pediatric intensive care unit (PICUS)in Aswan university hospital', EKB Journal Management System, (), pp. -. doi: 10.21608/aumj.2024.246809.1087
Moubarak, I., Elanany, M., Osman, A., Gabari, M., Mohammed, I., Moubarak, I. Procalcitonin (PCT) as a biomarker in hospital acquired septicemia in neonatal intensive care unit (NICUS) and pediatric intensive care unit (PICUS)in Aswan university hospital. EKB Journal Management System, 2024; (): -. doi: 10.21608/aumj.2024.246809.1087

Procalcitonin (PCT) as a biomarker in hospital acquired septicemia in neonatal intensive care unit (NICUS) and pediatric intensive care unit (PICUS)in Aswan university hospital

Aswan University Medical Journal
Articles in Press, Accepted Manuscript, Available Online from 12 February 2024  XML
Document Type: Original Article
DOI: 10.21608/aumj.2024.246809.1087
View on SCiNiTO View on SCiNiTO
Authors
Islam Ahmed Moubarak email 1; Mervat Elanany2; Asmaa Osman3; Magda Farghalli Gabari4; Islam Mohammed5; Islam Ahmed Moubarak6
1clinical pathology, Faculty of medicine, Aswan university, Aswan, Egypt
2Department of clinical pathology, Faculty of medicine , Cairo University, Cairo, Egypt.
3Department of clinical pathology, Faculty of medicine, Assiut University, Assiut, Egypt.
4Pediatrics department, Aswan university hospital, Aswan, Egypt
5Department of clinical pathology, Faculty of medicine , Aswan University, Aswan, Egypt.
6clinical pathology, faculty of medicine, Aswan university, aswan, Egypt
Abstract
Background: Sepsis is a life-threatening illness that results from an infection that damages tissues and organs. Sepsis causes shock, multiple organ failure, and death, especially if not detected and treated swiftly. The most recent definition of sepsis is infection with evidence of organ failure. Objectives: to evaluate the use of biomarkers for early detection of septicemia and its prognosis in order to guide antibiotic treatment. Patient and methods:This is a case control study that was done at the pediatric intensive care unit and the neonatal intensive care unit in Aswan University Hospital for 20 patients with suspected hospital-acquired septicemia and 20 non-septic patients as a control. Results: The mean levels of procalcitonin (PCT) and C-reactive protein (CRP) were considerably greater in the sepsis group than the control group, with a consistent decline over time in accordance with treatment and strong predictive power.Conclusion: Procalcitonin and C-reactive protein may be useful biomarkers for detecting nosocomial sepsis and predicting its outcome.
Keywords
Sepsis; procalcitonin; CRP
Statistics
Article View: 30